Cited by 10Muscle metabolism and nutritionMuscle Physiology and DisordersErythropoietin and Anemia Treatment

Erythropoietin does not enhance skeletal muscle protein synthesis following exercise in young and older adults

Open access
Lamon, Séverine, Zacharewicz, Evelyn, Arentson-Lantz, Emily, Gatta, Paul A. Della, Ghobrial, Lobna, Gerlinger-Romero, Frederico, Garnham, Andrew, Paddon-Jones, Douglas +1 more·2016·Frontiers in Physiology

Abstract

PURPOSE: Erythropoietin (EPO) is a renal cytokine that is primarily involved in hematopoiesis while also playing a role in non-hematopoietic tissues expressing the EPO-receptor (EPOR). The EPOR is present in human skeletal muscle. In mouse skeletal muscle, EPO stimulation can activate the AKT serine/threonine kinase 1 (AKT) signaling pathway, the main positive regulator of muscle protein synthesis. We hypothesized that a single intravenous EPO injection combined with acute resistance exercise would have a synergistic effect on skeletal muscle protein synthesis via activation of the AKT pathway. METHODS: Ten young (24.2 ± 0.9 years) and 10 older (66.6 ± 1.1 years) healthy subjects received a primed, constant infusion of [ring-13C(6)] L-phenylalanine and a single injection of 10,000 IU epoetin-beta or placebo in a double-blind randomized, cross-over design. 2 h after the injection, the subjects completed an acute bout of leg extension resistance exercise to stimulate skeletal muscle protein synthesis. RESULTS: Significant interaction effects in the phosphorylation levels of the members of the AKT signaling pathway indicated a differential activation of protein synthesis signaling in older subjects when compared to young subjects. However, EPO offered no synergistic effect on vastus lateralis mixed muscle protein synthesis rate in young or older subjects. CONCLUSIONS: Despite its ability to activate the AKT pathway in skeletal muscle, an acute EPO injection had no additive or synergistic effect on the exercise-induced activation of muscle protein synthesis or muscle protein synthesis signaling pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphys.2016.00292

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A sample size of 13 was calculated to minimize the risk of type II error for the primary outcome FSR (β = 0.2, α = 0.05).

    “Using data from studies investigating the effects of an anabolic and catabolic stimulus (e.g., immobilization or exercise) on changes in muscle protein synthesis (Lamon et al., 2016; Paddon‐Jones et al., 2006), power analyses conducted on our primary outcome (FSR) indicated that a sample size of 13 would minimize the risk of type II error (β = 0.2,α = 0.05).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lamon, S., Zacharewicz, E., Arentson-Lantz, E., Gatta, P. A. D., Ghobrial, L., Gerlinger-Romero, F., Garnham, A., Paddon-Jones, D., & Russell, A. P.
Affiliations
Deakin University (AU)
Corresponding author
Lamon, Séverine
Venue
Frontiers in Physiology
Published
2016-07-08
Volume
7
Pages
292-292
ISSN
1664-042X (ISSN-L)
OpenAlex
W2468722352
Cited by
10
References
57
Citations by year
2026: 2 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2017: 1
FWCI
0.23
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Physiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
  • Research Bank (Australian Catholic University) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PBLAP3-131833, PBLAP3-137051)
  • Deakin University (RM24071, RM24183)
  • State Government of Victoria (2015 Victoria Fellowship)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
erythropoietin, skeletal muscle protein synthesis, resistance training, Akt signaling, epoetin beta, EPO receptor, aging, older adults, vastus lateralis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review